UroToday - Overactive Bladder (OAB)

Home

Overactive Bladder (OAB)

Overactive Bladder

UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Display

results per page

Results 106 - 120 of 671

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Improvements in Overactive Bladder Syndrome after Polypropylene Mesh Surgery for Cystocele - Abstract
Wednesday, 17 June 2009
Reconstructive Pelvic Surgery, Yokosuka Urogynecology and Urology Clinic, Yokosuka, Kanagawa, Japan.
read more

Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study - Abstract
Wednesday, 17 June 2009
Department of Urology, Olomouc University Hospital, Olomouc, Czech Republic.
read more

Burden of Illness Associated With Lower Urinary Tract Symptoms Including Overactive Bladder/Urinary Incontinence - Abstract
Tuesday, 16 June 2009
Consumer Health Sciences, Princeton, New Jersey.
read more

Has Botulinum Toxin Therapy Come of Age: What Do We Know, What Do We Need To Know, and Should We Use It? - Abstract
Tuesday, 16 June 2009
Department of Urology, Hospital S. João, Porto, Portugal.
read more

Differentiating Interstitial Cystitis from Similar Conditions Commonly Seen in Gynecologic Practice - Abstract
Monday, 15 June 2009
Generations OB/GYN, 9430 Park West, Boulevard #320 Parkwest Tower, Knoxville, TN 37923, USA.
read more

Lower Urinary Tract Symptoms in Women - Abstract
Monday, 15 June 2009
Department of Obstetrics and Gynecology, Sahlgrenska Academy at Gothenburg University, Sahlgrenska University Hospital, Gothenburg, Sweden.
read more

World Continence Week - June 22 - 28, 2009 - Call for Support
Monday, 15 June 2009
BERKELEY, CA (News Release) - The Continence Promotion Committee (CPC) of the International Continence Society is observing the first World Continence Week from June 22nd through 28th.
read more

InterStim Therapy: A Contemporary Approach to Overactive Bladder - Abstract
Friday, 12 June 2009
Division of Urogynecology, Brigham and Women's Hospital, Department of Obstetrics and Gynecology, Harvard Medical School Boston, MA.
read more

Improvement in Quality of Life After Botulinum Toxin-A Injections for Idiopathic Detrusor Overactivity: Results from a Randomized Double-Blind Placebo-Controlled Trial - Abstract
Thursday, 11 June 2009
Department of Urology Guy's Hospital and King's College London School of Medicine, London, UK.
read more

The Long-Term Natural History of Overactive Bladder Symptoms Due to Idiopathic Detrusor Overactivity in Women - Abstract
Wednesday, 10 June 2009
Bristol Urological Institute, Southmead Hospital, Bristol, UK.
read more

NIDDK UI Symposium - Role of Urodynamic Testing - Session Highlights
Tuesday, 09 June 2009
BETHESDA, MD, USA (UroToday.com) - In this session, Dr. Charles Nager provided a summary of the role of urodynamic (UD) testing and the areas for future research.
Login to read more...

NIDDK UI Symposium - Incontinence in LUTS in Women - Session Highlights
Tuesday, 09 June 2009
BETHESDA, MD, USA (UroToday.com)
Login to read more...

Listening to the Patient: A Flexible Approach to the Use of Antimuscarinic Agents in Overactive Bladder Syndrome - Abstract
Tuesday, 09 June 2009
Mid-Michigan Health Centers, Jackson, MI, USA.
read more

Urodynamic Findings of the Painful Bladder Syndrome/Interstitial Cystitis: A Comparison with Idiopathic Overactive Bladder - Abstract
Monday, 08 June 2009
Department of Urology, Seoul National University Hospital, Seoul National University of Medicine, Seoul, Korea.
read more

AUA 2009 - The Dropped Bladder - SUFU Meeting - Session Highlights
Friday, 05 June 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Sandip Vasavada provided an informative review of cystocele repair and the effect on voiding dysfunction.
Login to read more...

Focus on Overactive Bladder

Focus on Overactive Bladder condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Podcast - Effective Darifenacin Treatment after Dissatisfaction with Prior Extended-Release Antimuscarinic Therapy

World Continence Week 2009

Patient Guide - Controlling Your Bladder Symptoms

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Promoting Continence Worldwide

- Prepared by Diane K. Newman, MSN, CRNP, FAAN, BCIA-PMDM

Urinary Incontinence: Epidemiology and Disease Burden
- Prepared by Alan J. Wein, MD, PhD (hon)

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years
- by Brian Olshansky, MD

Darifenacin Treatment for Overactive Bladder in Patients Who Expressed Dissatisfaction With Prior Extended-Release Antimuscarinic Therapy
- by Norman Zinner, MD, et al.

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
- by Alexander Roosen, MD and Clare J. Fowler, MD

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder
- by Giacomo Novara, MD, FEBU

Emerging Drugs for Treatment of Overactive Bladder and Detrusor Overactivity
- by Marcus Drake, MD

Two Types of Urgency
- by Philip M. Hanno, MD, MPH - Editor's Pick

Long-Term Efficacy and Safety of Tolterodine in Children with Neurogenic Detrusor Overactivity
- by Pasquale Casale, MD

Defining Overactive Bladder as Hypersensitivity
- by Philip M. Hanno, MD, MPH

Minimally Invasive Therapy for Neurogenic Detrusor Overactivity: A Review
- by Karl-Erik Andersson, Roger Dmochowski and Alan Wein

A Randomized Controlled Study of Posterior Tibial Nerve Stimulation for Overactive Bladder
- by Paula Palma, MD, PhD. et al.

Efficacy and Tolerability of Add-On Trospium Chloride in Patients with Benign Prostate Syndrome and Overactive Bladder: A Noninterventional Trial Showing Use of Flexible Dosing
- by Ulrich Schwantes, PhD, et al.

The second-line management of idiopathic overactive bladder: What is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?

On the Origins of the Sensory Output from the Bladder: The Concept of Afferent Noise

A Review of Adherence to Drug Therapy in Patients with Overactive Bladder

Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience

Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study
- by Michael Chancellor, MD, et al.

Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release
- by Michael G. Oefelein, MD, et al.

Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery
- by Michael Chancellor, MD.

The evolution of transdermal therapy for overactive bladder
- by Peter K. Sand, MD

Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder
- by Michael K. Flynn, MD, et al.

InterStim Therapy: A Contemporary Approach to Overactive Bladder
- by Neeraj Kohli, MD, MBA and Danielle Patterson, MD

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years
- by Brian Olshansky, MD, et al.

Randomized Comparison of Tolterodine With Vaginal Estrogen Cream Versus Tolterodine Alone for the Treatment of Postmenopausal Women With Overactive Bladder Syndrome
- by Ling-Hong Tseng, MD, et al.

The role of industry funding in randomized controlled trials of antimuscarinic medications for overactive bladder
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

State of the Art Lecture: Bladder re-innervation: Can new nerves improve the function of the neurogenic bladder?
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Is ultrasound bladder wall thickness a better measure than urodynamics for overactive bladder symptoms?
- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Urodynamics/Incontinence/Female Urology: Urodynamic Testing - Identification of Measures of Bladder Sensation in Patients with Overactive Bladder
- Session Highlight by Kathleen Kobashi, MD from the 2009 Annual Meeting of the American Urological Association (AUA)

Session Highlights from the Society for Urodynamics & Female Urology 2009 Winter Meeting
- Exclusive Coverage by UroToday Contributing Medical Editor, William Jaffe, MD

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at The National Institutes of Health (NIH) - UI Symposium
- Session Highlights Reported by Diane K. Newman

Drug Treatment - Lecture Series

- Presented by Karl-Erik Andersson, MD, PhD, and Christopher Chapple, MD, et al. at the Fourth International Consultation on Incontinence (ICI)

Drug Treatment - Committee Meeting Highlights

- Reported by William Jaffe, MD from the Fourth International Consultation on Incontinence (ICI)

Voiding Dysfunction Session Highlights

- From the American Urological Association 2008 Annual Meeting

Urodynamics and Reality

- Presented by Ed McGuire, MD, at the 32nd Winter Urologic Forum

Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder
- Presented at the European Association of Urology - 23rd Annual EAU Congress

International Consultation on Incontinence - ICI 2008
- Session Abstracts, Overactive Bladder